PRASAD VARMA S PENMETSA
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology ROCHESTER, NY NPI 1891750451
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NY PENTAX OF AMERICA, INC. All categories
General Payments — all program years on this page
$8,883.45
- Category: General Payments
- Program years: PY2018–2024
- Record count: 484
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,035.43 across 69 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,493.21 | 67 |
| Long term medical supply or device loan | $542.22 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PENTAX OF AMERICA, INC. | $576.42 | 3 |
| ABBVIE INC. | $415.02 | 23 |
| Janssen Biotech, Inc. | $162.98 | 8 |
| Celgene Corporation | $144.89 | 1 |
| Gilead Sciences, Inc. | $104.37 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $101.35 | 5 |
| Phathom Pharmaceuticals, Inc. | $77.86 | 3 |
| Merck Sharp & Dohme Corporation | $61.54 | 3 |
| INTERCEPT PHARMACEUTICALS, INC. | $59.29 | 3 |
| Ferring Pharmaceuticals Inc. | $50.93 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $50.41 | 3 |
| IRONWOOD PHARMACEUTICALS, INC | $38.21 | 2 |
| GENZYME CORPORATION | $37.71 | 1 |
| QOL Medical, LLC | $35.86 | 1 |
| Lilly USA, LLC | $33.17 | 2 |
| Ardelyx, Inc. | $25.70 | 1 |
| Organon LLC | $23.19 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.21 | 1 |
| PFIZER INC. | $16.32 | 1 |
By program year
Records — PY2024 (69)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.